Jeffrey S. Grand
Jeffrey S. Grand graduated from the Benjamin N. Cardozo School of Law in 2002, where he was the executive editor of the Cardozo Law Review, a member of the Order of the Coif, and received the Felix Frankfurter Award. He received his B.F.A. from the New York School of Visual Arts in 1990.
Mr. Grand joined the Firm in 2011, and his practice is focused on pharmaceutical and mass tort litigation. He was recently appointed co-liaison counsel in In re Pelvic Mesh Litigation, No. 006341-10 (N.J. Super. Ct.), where he will assist in leading the cases against C.R. Bard, Johnson & Johnson subsidiary Ethicon, and other defendants.
Mr. Grand has extensive experience in pharmaceutical and mass tort litigation, having actively litigated high-profile cases involving prescription drugs including Vioxx, Fosamax and Yaz. He has supervised the day-to-day management of complex, multi-party mass tort litigation in state and federal courts and multi-district litigation throughout the United States, and has served on discovery and administrative committees in these litigations. He has served as a member of the trial teams that obtained a $47.5 million verdict for Vioxx-related cardiovascular injury in Humeston v. Merck & Co., No. L-2272-03 (N.J. Super. Ct.) in 2007, and several plaintiff victories in the Chinese-Manufactured Drywall Products Liability Litigation, No. MDL 2047 (E.D. La.). He also has extensive experience in the area of electronic discovery, most recently having served as a co-chair for electronic discovery in the Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010 Litigation, No. 10-md-02179-CJB-SS (E.D. La.).
Prior to joining the Firm, Mr. Grand was a partner at a prominent plaintiffs’ pharmaceutical and mass tort law firm. He is admitted to practice in the State of New York, and the United States District Courts for the Southern and Eastern Districts of New York.